These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36541699)

  • 1. Noninvasive Imaging of Tumor PD-L1 Expression Using [
    Zhang Y; Ding Y; Li N; Wang S; Zhou S; Li R; Yang H; Li W; Qu J
    Mol Pharm; 2023 Jan; 20(1):690-700. PubMed ID: 36541699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
    Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
    Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Phase I Study of a
    Xing Y; Chand G; Liu C; Cook GJR; O'Doherty J; Zhao L; Wong NCL; Meszaros LK; Ting HH; Zhao J
    J Nucl Med; 2019 Sep; 60(9):1213-1220. PubMed ID: 30796165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive Evaluation of Tumoral PD-L1 Using a Novel
    Hu B; Ma X; Shi L; Liu T; Li L; Yao M; Li C; Jia B
    Mol Pharm; 2024 Apr; 21(4):1977-1986. PubMed ID: 38395797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy.
    Gao H; Wu Y; Shi J; Zhang X; Liu T; Hu B; Jia B; Wan Y; Liu Z; Wang F
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of [
    Liu T; Wu Y; Shi L; Li L; Hu B; Wang Y; Gao H; Yu X; Zhang X; Zhao H; Wan Y; Jia B; Wang F
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1810-1821. PubMed ID: 35013776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (99m)Tc-labeled SWL specific peptide for targeting EphA2 receptor.
    Liu Y; Lan X; Wu T; Lang J; Jin X; Sun X; Wen Q; An R
    Nucl Med Biol; 2014 Jul; 41(6):450-6. PubMed ID: 24768147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and preliminary biological evaluation of a novel
    Zhu D; Xu X; Zou P; Liu Y; Wang H; Han G; Lu C; Xie M
    Bioorg Med Chem Lett; 2023 Nov; 96():129496. PubMed ID: 37797805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigations of (99m)Tc-labeled glucarate as a SPECT radiotracer for non-small cell lung cancer (NSCLC) and potential tumor uptake mechanism.
    Meng L; Xiu Y; Li Y; Xu X; Li S; Li X; Pak KY; Shi H; Cheng D
    Nucl Med Biol; 2015 Jul; 42(7):608-13. PubMed ID: 25890861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8
    Ertveldt T; Meulewaeter S; De Vlaeminck Y; Olarte O; Broos K; Van Calenbergh S; Bourgeois S; Deprez J; Heremans Y; Goyvaerts C; Staels W; De Smedt S; Dewitte H; Devoogdt N; Keyaerts M; Verbeke R; Barbé K; Lentacker I; Breckpot K
    Theranostics; 2023; 13(15):5483-5500. PubMed ID: 37908728
    [No Abstract]   [Full Text] [Related]  

  • 11. A Novel Small Cyclic Peptide-Based
    Liu H; Hu M; Deng J; Zhao Y; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Mol Pharm; 2022 Jan; 19(1):138-147. PubMed ID: 34910492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
    Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
    Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Vats K; Chakraborty A; Rakshit S; Damle A; Sarma HD; Satpati D
    Nucl Med Biol; 2023; 118-119():108331. PubMed ID: 36933456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe
    Li L; Wu Y; Wang Z; Jia B; Hu Z; Dong C; Wang F
    J Nucl Med; 2017 May; 58(5):821-826. PubMed ID: 28104744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
    Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
    Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging diagnosis and efficacy monitoring by [
    He H; Qi X; Fu H; Xu J; Zheng Q; Chen L; Zhang Y; Hua H; Xu W; Xu Z; Chen X; You Q; Lin J; Huang G; Mao Y; Yu C
    Theranostics; 2024; 14(1):392-405. PubMed ID: 38164149
    [No Abstract]   [Full Text] [Related]  

  • 17. Application of
    Fan M; Yao J; Zhao Z; Zhang X; Lu J
    Pharmaceuticals (Basel); 2024 Jul; 17(7):. PubMed ID: 39065756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Radioimmune
    Ye M; Gai Y; Ji H; Jiang Y; Qiao P; Wang W; Zhang Y; Xia X; Lan X
    Front Immunol; 2021; 12():660842. PubMed ID: 34484174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPECT Imaging of Treatment-Related Tumor Necrosis Using Technetium-99m-Labeled Rhein.
    Liang J; Luo Q; Zhang D; Jin Q; Liu L; Liu W; Gao M; Zhang J; Yin Z
    Mol Imaging Biol; 2019 Aug; 21(4):660-668. PubMed ID: 30338432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc-labeled estradiol as an estrogen receptor probe: Preparation and preclinical evaluation.
    Xia X; Feng H; Li C; Qin C; Song Y; Zhang Y; Lan X
    Nucl Med Biol; 2016 Jan; 43(1):89-96. PubMed ID: 26466867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.